Monday, May 12, 2008

StemCells still going after Neuralstem

Forbes (AP) reports on May 12: Clinical-stage biotechnology company StemCells Inc. said Monday [May 12] it filed a second patent lawsuit against Neuralstem in a California federal court, alleging infringement of two patents related to human neural stem cells.

There was the discussion of litigate vs. license:

"While we are disappointed that Neuralstem chose to escalate matters, we have a duty to our shareholders to protect our good name and the significant value of our intellectual property portfolio built over the years," StemCells Chief Executive Officer Martin McGlynn said in a statement. "Litigation of this type can be very time consuming and expensive and might have been avoided had Neuralstem chosen to negotiate a license as others have."

See also


Post a Comment

<< Home